2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

European Soc Cardiology, European Atherosclerosis Soc, Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Marja-Riitta Taskinen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Heart Journal
Volume41
Issue number1
Pages (from-to)111-188
Number of pages78
ISSN0195-668X
DOIs
Publication statusPublished - 1 Jan 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Guidelines
  • dyslipidaemias
  • cholesterol
  • triglycerides
  • low-density lipoproteins
  • high-density lipoproteins
  • apolipoprotein B
  • lipoprotein(a)
  • lipoprotein remnants
  • total cardiovascular risk
  • treatment (lifestyle)
  • treatment (drugs)
  • treatment (adherence)
  • very low-density lipoproteins
  • familial hypercholesterolaemia
  • DENSITY-LIPOPROTEIN CHOLESTEROL
  • CORONARY-HEART-DISEASE
  • C-REACTIVE PROTEIN
  • HIGH-DOSE ATORVASTATIN
  • TYPE-2 DIABETES-MELLITUS
  • ALL-CAUSE MORTALITY
  • HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
  • STATIN-TREATED PATIENTS
  • INTIMA-MEDIA THICKNESS
  • CHRONIC KIDNEY-DISEASE
  • 3121 Internal medicine

Cite this